XML 14 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Income - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Net sales $ 95,031 $ 86,333 $ 271,239 $ 259,255
Cost of sales [1] 75,432 67,708 213,248 202,764
Gross profit 19,599 18,625 57,991 56,491
Selling, general and administrative expenses 7,584 8,154 24,455 24,114
Operating income 12,015 10,471 33,536 32,377
Gain on sale of equity method investment 0 11,381 0 11,381
Equity method investment loss 0 0 0 (348)
Interest expense, net (334) (224) (830) (934)
Income before income taxes 11,681 21,628 32,706 42,476
Income tax expense 2,673 7,491 7,244 13,292
Net income 9,008 14,137 25,462 29,184
Income attributable to participating securities 174 414 491 806
Net income attributable to common shareholders and used in EPS calculation $ 8,834 $ 13,723 $ 24,971 $ 28,378
Share information:        
Basic and Diluted weighted average common shares (in shares) 16,872,091 16,751,346 16,861,700 16,735,378
Basic and diluted earnings per common share (in dollars per share) $ 0.52 $ 0.82 $ 1.48 $ 1.70
Dividends and dividend equivalents per common share (in dollars per share) $ 0.08 $ 0.89 $ 0.24 $ 0.97
[1] Includes related party purchases of $0 and $18,425 for year to date September 30, 2018 and 2017, respectively. There were no related party purchases for the quarters ended September 30, 2018 and 2017.